Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    23223178 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
Conditions: Atrial Fibrillation;   Atrial Flutter
Interventions: Drug: bucindolol hydrochloride;   Drug: metoprolol succinate

Indicates status has not been verified in more than two years